The FDA has cleared PrecivityAD2, a single blood test designed to help health care professionals rule in or rule out an ...

Alzheimer’s dementia is generally more prevalent in women than in men, and doctors believe that one reason why is the sudden ...

A new study suggests that Alzheimer's disease may be detected by brain imaging more than seven years earlier than previously ...

C2N’s Alzheimer’s test is the first to be FDA-cleared for use in patients as young as 40 who present with cognitive ...

Researchers found that a metabolite produced by gut bacteria can weaken the barrier that protects the brain and promote ...

Experts have spoken about the signs and symptoms, whether there are gender differences and how people with Alzheimer’s can be ...

In 2025, the U.S. awarded 52% fewer grants related to Alzheimer's research than in 2024, according to the National Institutes ...

The U.S. Food and Drug Administration (FDA) has cleared for marketing an innovative blood test with underlying technology ...

Two groups studied the same cancer mutations in the blood. They agreed on many aspects, including the mechanism at work. But ...

Treatment with new oral anticoagulants (NOAC) may help slow the cognitive decline rate of people with both Alzheimer's ...

The Michigan Alzheimer’s Disease Research Center and Region 9 Area Agency on Aging, with support from the Michigan Department of Health and Human Services through the ACCESS-ADRD Grant, will host a ...

A new study suggests that women who used hormone therapy later in life may have had a lower risk of dementia and fewer signs ...